全文获取类型
收费全文 | 402篇 |
免费 | 17篇 |
国内免费 | 3篇 |
专业分类
儿科学 | 1篇 |
妇产科学 | 28篇 |
基础医学 | 179篇 |
口腔科学 | 3篇 |
临床医学 | 5篇 |
内科学 | 21篇 |
皮肤病学 | 1篇 |
神经病学 | 3篇 |
特种医学 | 1篇 |
外科学 | 24篇 |
综合类 | 8篇 |
眼科学 | 1篇 |
药学 | 3篇 |
肿瘤学 | 144篇 |
出版年
2023年 | 1篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2015年 | 5篇 |
2014年 | 2篇 |
2013年 | 20篇 |
2012年 | 12篇 |
2011年 | 7篇 |
2010年 | 7篇 |
2009年 | 4篇 |
2008年 | 12篇 |
2007年 | 14篇 |
2006年 | 26篇 |
2005年 | 23篇 |
2004年 | 31篇 |
2003年 | 25篇 |
2002年 | 20篇 |
2001年 | 20篇 |
2000年 | 18篇 |
1999年 | 17篇 |
1998年 | 7篇 |
1997年 | 8篇 |
1996年 | 4篇 |
1995年 | 6篇 |
1994年 | 4篇 |
1993年 | 8篇 |
1992年 | 13篇 |
1991年 | 7篇 |
1990年 | 12篇 |
1989年 | 15篇 |
1988年 | 15篇 |
1987年 | 8篇 |
1986年 | 12篇 |
1985年 | 24篇 |
1984年 | 6篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有422条查询结果,搜索用时 0 毫秒
71.
Liu H Tekle C Chen YW Kristian A Zhao Y Zhou M Liu Z Ding Y Wang B Mælandsmo GM Nesland JM Fodstad O Tan M 《Molecular cancer therapeutics》2011,10(6):960-971
In many types of cancer, the expression of the immunoregulatory protein B7-H3 has been associated with poor prognosis. Previously, we observed a link between B7-H3 and tumor cell migration and invasion, and in present study, we have investigated the role of B7-H3 in chemoresistance in breast cancer. We observed that silencing of B7-H3, via stable short hairpin RNA or transient short interfering RNA transfection, increased the sensitivity of multiple human breast cancer cell lines to paclitaxel as a result of enhanced drug-induced apoptosis. Overexpression of B7-H3 made the cancer cells more resistant to the drug. Next, we investigated the mechanisms behind B7-H3-mediated paclitaxel resistance and found that the level of Stat3 Tyr705 phosphorylation was decreased in B7-H3 knockdown cells along with the expression of its direct downstream targets Mcl-1 and survivin. The phosphorylation of Janus kinase 2 (Jak2), an upstream molecule of Stat3, was also significantly decreased. In contrast, reexpression of B7-H3 in B7-H3 knockdown and low B7-H3 expressing cells increased the phosphorylation of Jak2 and Stat3. In vivo animal experiments showed that B7-H3 knockdown tumors displayed a slower growth rate than the control xenografts. Importantly, paclitaxel treatment showed a strong antitumor activity in the mice with B7-H3 knockdown tumors, but only a marginal effect in the control group. Taken together, our data show that in breast cancer cells, B7-H3 induces paclitaxel resistance, at least partially by interfering with Jak2/Stat3 pathway. These results provide novel insight into the function of B7-H3 and encourage the design and testing of approaches targeting this protein and its partners. 相似文献
72.
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma 总被引:5,自引:0,他引:5
OBJECTIVES: To analyze expressions of the EphB2 and EphB4 receptors in ovarian carcinomas and explore their clinicopathological correlations and prognostic value. METHODS: 115 patients with advanced ovarian carcinoma FIGO IIB to IV were involved. RT-PCR and immunohistochemistry were used to examine the expressions of EphB2/B4 receptor mRNA and protein. Correlations between protein expression and clinicopathological factors were also analyzed. RESULTS: Ovarian carcinoma patients with age elder than 60 years had higher EphB2 expression than younger patients. Expression of EphB2 and EphB4 protein did not significantly correlate with any other clinical variables, including FIGO stage, residual tumor, histological type and differentiation grade. No significant correlation between mRNA and protein expression level for both of these receptors was seen. It was found that patients with strong immunostaining for EphB2 (P = 0.03) or EphB4 (P = 0.003) receptors had poorer survival, and patients with strong immunostaining for EphB4 receptor showed poorer response to chemotherapy (P = 0.036). CONCLUSIONS: These studies suggest that EphB2 and B4 receptors are of prognostic value and EphB4 receptor may be an independent predictor of chemotherapy response in ovarian cancer patients. 相似文献
73.
BACKGROUND: Breast cancer is the most common malignancy in women. Although an increasing number of patients with breast cancer are being cured by surgery, a considerable number of patients suffer relapse in the form of metastases after surgery. E-cadherin and catenins have documented roles in breast cancer progression. Mammography is supposed to decrease breast cancer mortality by detecting tumours while they are small and before they have reached a clinically detectable stage.Aim: In the present study, we wanted to evaluate whether there are differences in expression patterns of adhesion proteins, shown to be crucial in the metastatic process, between small tumours detected by mammography and clinically detected large tumours. METHODS: Expression of E-cadherin, alpha-catenin, beta-catenin and gamma-catenin was analysed using immunohistochemistry methods in 86 invasive breast carcinomas detected by mammography and compared with 90 clinically palpable invasive breast carcinomas. RESULTS: In the group of tumours detected by mammography (86 samples), reduced expression of E-cadherin was observed in 12 (14%) samples. Reduced expression of alpha-catenin was observed in four (4.6%) samples, and three (3.5%) samples showed reduced expression of beta-catenin. All samples showed strong expression of gamma-catenin. When expression patterns of these proteins were evaluated in 90 clinically detected tumours, we observed reduced expression of E-cadherin in 58 (64.4%) samples, 12 (13.3%) samples showed reduced expression of alpha-catenin, while nine (10%) samples showed reduced expression of beta-catenin. Strong expression of gamma-catenin was detected in all tumours also in this group.Statistical analyses revealed a highly significant difference in expression of E-cadherin (p<0.001). However, no statistically significant differences were observed in expression of alpha-catenin (p = 0.081) and beta-catenin (p = 0.092) between the two groups of tumours. CONCLUSION: Results indicate that T1 breast tumours harbour less alterations in E-cadherin-catenin complexes and therefore are probably less likely to disseminate, and patients probably have a better prognosis than if tumours are diagnosed as T2. 相似文献
74.
75.
M K Nygren C Tekle V A Ingebrigtsen R M?kel? M Krohn M R Aure C E Nunes-Xavier M Per?l? T Tramm J Alsner J Overgaard J M Nesland E Borgen A-L B?rresen-Dale ? Fodstad K K Sahlberg S-K Leivonen 《British journal of cancer》2014,110(8):2072-2080
Background:
B7-H3, an immunoregulatory protein, is overexpressed in several cancers and is often associated with metastasis and poor prognosis. Here, our aim was to identify microRNAs (miRNAs) regulating B7-H3 and assess their potential prognostic implications in breast cancer.Methods:
MicroRNAs targeting B7-H3 were identified by transfecting two breast cancer cell lines with a library of 810 miRNA mimics and quantifying changes of B7-H3 protein levels using protein lysate microarrays. For validations we used western immunoblotting and 3′-UTR luciferase assays. Clinical significance of the miRNAs was assayed by analysing whether their expression levels correlated with outcome in two cohorts of breast cancer patients (142 and 81 patients).Results:
We identified nearly 50 miRNAs that downregulated B7-H3 protein levels. Western immunoblotting validated the impact of the 20 most effective miRNAs. Thirteen miRNAs (miR-214, miR-363*, miR-326, miR-940, miR-29c, miR-665, miR-34b*, miR-708, miR-601, miR-124a, miR-380-5p, miR-885-3p, and miR-593) targeted B7-H3 directly by binding to its 3′-UTR region. Finally, high expression of miR-29c was associated with a significant reduced risk of dying from breast cancer in both cohorts.Conclusions:
We identified miRNAs efficiently downregulating B7-H3 expression. The expression of miR-29c correlated with survival in breast cancer patients, suggesting a tumour suppressive role for this miRNA. 相似文献76.
With the exception of patients with tumors smaller than 2cm and infiltration less than 1mm, standard treatment for squamous cell carcinomas of the vulva includes ipsi- or bilateral inguinofemoral lymph node dissection. However, with only 20% of early stage patients presenting with lymph node metastases in the groin, the majority of these patients do not gain from the procedure, but are at risk of its complications and detriments. The sentinel lymph node biopsy (SLNB) method targets the lymph nodes most likely to contain metastasis and has proven high accuracy in predicting the absence of metastasis in non-sentinel lymph nodes when found negative on pathologic examination. The SLNB further provides for a more thorough examination of the harvested lymph nodes and hence increases the detection of micrometastases. Although the clinical significance of micrometastases is controversial, reports on patients with micrometastasis suffering recurrence emerge, making the importance of detecting micrometastases in the pathologic examination of the sentinel lymph nodes evident. Appreciating its limitations, the sentinel lymph node procedure shows evidence of evolving into a feasible and safe procedure in the hands of experienced surgeons, pathologists and nuclear medicine physicians in early stage vulvar carcinoma patients. Still, larger multicenter trials are needed to assess its accuracy and safety. 相似文献
77.
Dong HP Kleinberg L Silins I Flørenes VA Tropé CG Risberg B Nesland JM Davidson B 《Cancer》2008,112(1):84-93
BACKGROUND: Death receptors mediate both apoptosis and survival in cancer cells. The authors analyzed death receptor expression in metastatic ovarian carcinoma. METHODS: Viable tumor cells in ovarian carcinoma effusions (n = 95) were analyzed for DR4, DR5, Fas, TNFR1, and TNFR2 expression using flow cytometry. Results were analyzed for association with clinicopathologic parameters, chemotherapy response, and survival. RESULTS: DR4, DR5, and Fas were expressed by the majority of specimens, with less frequent expression of TNFR1 and TNFR2. DR4 (P = .005) and TNFR2 (P = .041) expression was higher in FIGO stage IV compared with stage III tumors. Effusions from patients who responded poorly to chemotherapy administered at disease recurrence had significantly higher DR4 (P = .006), DR5 (P = .01), and Fas (P = .001) expression. In univariate survival analysis, higher DR4 expression in viable cells correlated with poor overall (P = .0352) and progression-free (P = .0411) survival. DR4 expression was found to be an independent predictor of overall (P = .008) and progression-free (P = .003) survival. CONCLUSIONS: The authors have presented the first evidence of death receptor coexpression in ovarian carcinoma effusions. The association of death receptor expression in effusions with advanced stage, poor response to chemotherapy, and shorter survival suggests that these molecules are linked to an aggressive clinical course in metastatic ovarian carcinoma. 相似文献
78.
79.
Goscinski MA Suo ZH Nesland JM Chen WT Zakrzewska M Wang J Zhang S Flørenes VA Giercksky KE 《Oncology》2008,75(1-2):49-59
80.
CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. 总被引:3,自引:0,他引:3
Nurija Bilalovic Berit Sandstad Rastko Golouh Jahn M Nesland Ivan Selak Emina E Torlakovic 《Modern pathology》2004,17(10):1251-1258
CD10 antigen is a 100-kDa-cell surface zinc metalloendopeptidase expressed in a variety of normal and neoplastic lymphoid and nonlymphoid tissues including melanomas. It was recently shown that metastatic melanomas express more CD10 than primary tumors. We evaluated CD10 expression in tumor and stromal cells in 70 biopsies with primary and 28 with metastatic malignant melanomas. Ki-67, Bcl-2, and Bax were also examined to investigate whether CD10 expression is associated with tumor proliferation index or factors of apoptosis. Formalin-fixed/paraffin-embedded tissues were studied by immunohistochemistry. More advanced primary tumors had higher CD10 expression in the tumor cells (r = 0.27, P = 0.03 for Clark levels and r = 0.29, P = 0.02 for Breslow) and higher Ki-67 proliferation fraction (r = 0.32, P = 0.007 for Clark levels and r = 0.32, P = 0.001 for Breslow). Similarly, CD10 expression in the intratumoral stromal cells was also higher in primary tumors with higher Clark level (P = 0.04, linear-by-linear association) and tumor thickness according to Breslow (r = 0.33, P = 0.01). The presence of CD10+ peritumoral stromal cell cuffs was also positively associated with tumor thickness according to Breslow (r = 0.27, P = 0.05). Also, expression of CD10 and Ki-67 were significantly higher in metastatic than in primary tumors (P = 0.01 and 0.02 respectively), but Bcl-2 expression was higher in primary melanomas (P = 0.02). We conclude that CD10 expression in malignant melanoma is associated with tumor progression. 相似文献